In 2023, Strides Pharma Science completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Strides Pharma Science has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Strides Pharma Science’s data sources below and access millions more through our Disclosure Search.
In 2023, the total operational greenhouse gas (GHG) emissions of Strides Pharma Science amounted to 25,553 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Strides Pharma Science decreased by 2.34%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
In 2023, the total Scope 1 emissions of Strides Pharma Science were 6,168 metric tons of CO₂ equivalent (tCO₂e). a
Compared to the previous year (2022), Strides Pharma Science's Scope 1 emissions remained relatively stable, indicating that Strides Pharma Science's emissions have plateaued with no significant change in its operational footprint. a
In 2023, Strides Pharma Science reported Scope 2 greenhouse gas (GHG) emissions of 19,385 tCO₂e without specifying the calculation method. a
Compared to the previous year (2022), Strides Pharma Science's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Strides Pharma Science 's emissions have plateaued with no significant change in its energy consumption footprint. a
In 2023, Strides Pharma Science reported its Scope 2 emissions using an unspecified methodology. a
In 2023, Strides Pharma Science reported Scope 1 greenhouse gas (GHG) emissions of 6,168 tCO₂e and total revenues of USD 439 millions. This translates into an emissions intensity of 14.04 tCO₂e per millions USD. a
In 2023, Strides Pharma Science reported a Scope 1 emissions intensity of 14.04 tCO₂e per millions USD. Compared to the peer group median of 28.64 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
In 2023, Strides Pharma Science ranked 8 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Strides Pharma Science is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a